Jingoism buried, IPO done, stock price up 50%. What next for Gland Pharma?
Its IPO was talk of the town, but investors gave it a miss. Now, the company is having the last laugh
V Keshavdev - December 10, 2020
How KKR India reached a debt end
The marquee private equity firm’s strategy of lending to growth companies and risky turnarounds has backfired badly, denting its reputation as a savvy financier
Krishna Gopalan - January 24, 2020
Throwing good money after bad
The story of how the chase for high yield ended up hurting KKR India's debt portfolio
N Mahalakshmi - January 27, 2020
Fall from grace
Once celebrated as the turnaround genius, Gautam Thapar is today fighting to get back into the company that he once rescued. What led to this descent?
Krishna Gopalan - September 30, 2019
Once a turnaround genius, promoter Gautam Thapar was ousted by his own board. Are other boardrooms going to take note?
N Mahalakshmi - September 23, 2019
The Big Fight for Fortis
Despite promoter woes and possible contingent liabilities, Fortis is an asset that many are willing to fight over
Kripa Mahalingam - April 23, 2018
Sanjay and Falguni Nayar’s globetrotting taught their kids to fend for themselves
Naini Thaker - January 04, 2018
Down but not out
A sluggish realty market has not deterred private equity investors from pumping money into the sector
May 25, 2016
Falguni & Sanjay Nayar
Falguni, founder, Nykaa & Sanjay Nayar, CEO, KKR India, on striking the right balance between work and family
Krishna Gopalan - May 25, 2015
Changing with the times
Pantaloons' new owners are keen to move up the value chain and set up more stores. Will the aggressive bet pay off?
Meghna Maiti - December 15, 2014